Eryped 200
Pricing Report NDC 0074-6302-13
Current Package Pricing Information
The latest wholesale acquisition cost for Eryped 200 (NDC 0074-6302-13) is $1.75748 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Feb 28, 2014.
As a provided by Abbvie Inc., this medication is distributed in a 100 mL in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.
NADAC Pricing Summary
NADAC pricing snapshot for this package NDC
Acquisition Cost $1.75748 Per ML
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
Historical Pricing Trends & Acquisition Cost Benchmarks
Since Oct 2013, the NADAC wholesale price for (NDC ) has moved within a range of $1.35190 to $1.75748 per ML. Over this 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.
$1.3519 - $1.7575
30.00% Variance
30.00%
| Date | Unit Price | Unit | Source | Method | Rate |
|---|---|---|---|---|---|
| Feb 28, 2014 | $1.75748 | ML | C/I - Chain or Independent Pharmacy | Code 2, 5, 6 | B - Brand |
| Feb 28, 2014 | $1.75748 | ML | C/I - Chain or Independent Pharmacy | Code 3, 5, 6 | B - Brand |
| Oct 01, 2013 | $1.35190 | ML | C/I - Chain or Independent Pharmacy | Code 2, 5, 6 | B - Brand |
Pricing Methodology Legend
- Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
- Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
- Code 5: The NADAC was calculated based on package size.
- Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
Understanding NADAC Pricing Data
The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.
Important Price Distinction:
The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.
NADAC Pricing Data Last Updated on: July 08, 2026
